Reins Rose Yvonne, Baidouri Hasna, McDermott Alison Marie
Invest Ophthalmol Vis Sci. 2015 Dec;56(13):7715-27. doi: 10.1167/iovs.15-17768.
Vitamin D is recognized to be an important modulator of the immune system. In the eye, studies have shown that deficiencies and genetic differences in vitamin D-related genes have a significant impact on the development of various ocular diseases. Our current study examines the ability of human corneal epithelial cells (HCEC) to activate vitamin D and the effect of vitamin D treatment on antimicrobial peptide production and cytokine modulation during inflammation, with the ultimate goal of using vitamin D therapeutically for corneal inflammation.
Human corneal epithelial cells were treated with 10-7M vitamin D3 (D3) or 25-hydroxyvitamin D3 (25D3) for 24 hours and 1,25-dihydroxyvitamin D3 (1,25D3) detected by immunoassay. Human cathelicidin (LL-37) expression was examined by RT-PCR, immunoblot, and immunostaining following 1,25D3 treatment and antimicrobial activity of 1,25D3-treated cells was determined. Cells were stimulated with TLR3 agonist polyinosinic-polycytidylic acid (Poly[I:C]) for 24 hours and cytokine levels measured by RT-PCR, ELISA, and Luminex. Immunostaining determined expression of vitamin D receptor (VDR) and retinoic acid inducible gene-1 receptor (RIG-1) as well as NF-κB nuclear translocation.
When treated with inactive vitamin D metabolites, HCEC produced active 1,25D3, leading to enhanced expression of the antimicrobial peptide, LL-37, dependent on VDR. 1,25-D3 decreased the expression of proinflammatory cytokines (IL-1β, IL-6, TNFα, and CCL20) and MMP-9 induced by Poly(I:C) as well as pattern recognition receptor expression (TLR3, RIG-1, MDA5). However, early activation of NF-κB was not affected.
These studies demonstrate the protective ability of vitamin D to attenuate proinflammatory mediators while increasing antimicrobial peptides and antipseudomonas activity in corneal cells, and further our knowledge on the immunomodulatory functions of the hormone.
维生素D被认为是免疫系统的重要调节因子。在眼部,研究表明维生素D相关基因的缺陷和遗传差异对各种眼部疾病的发展有重大影响。我们目前的研究考察了人角膜上皮细胞(HCEC)激活维生素D的能力以及维生素D治疗对炎症期间抗菌肽产生和细胞因子调节的影响,最终目标是将维生素D用于角膜炎症的治疗。
用人角膜上皮细胞分别用10-7M维生素D3(D3)或25-羟基维生素D3(25D3)处理24小时,并用免疫测定法检测1,25-二羟基维生素D3(1,25D3)。在1,25D3处理后,通过RT-PCR、免疫印迹和免疫染色检测人cathelicidin(LL-37)的表达,并测定1,25D3处理细胞的抗菌活性。用TLR3激动剂聚肌苷酸-聚胞苷酸(Poly[I:C])刺激细胞24小时,并通过RT-PCR、ELISA和Luminex测定细胞因子水平。免疫染色确定维生素D受体(VDR)和视黄酸诱导基因-1受体(RIG-1)的表达以及NF-κB核转位。
当用无活性的维生素D代谢物处理时,HCEC产生活性1,25D3,导致抗菌肽LL-37的表达增强,这依赖于VDR。1,25-D3降低了由Poly(I:C)诱导的促炎细胞因子(IL-1β、IL-6、TNFα和CCL20)以及基质金属蛋白酶-9的表达以及模式识别受体表达(TLR3、RIG-1、MDA5)。然而,NF-κB的早期激活不受影响。
这些研究证明了维生素D在角膜细胞中减弱促炎介质同时增加抗菌肽和抗假单胞菌活性的保护能力,并进一步拓展了我们对该激素免疫调节功能的认识。